Home » Quidel Gets Emergency Clearance for COVID-19 Diagnostic
Quidel Gets Emergency Clearance for COVID-19 Diagnostic
Quidel has received an Emergency Use Authorization from the FDA for its Sofia 2 rapid antigen COVID-19 diagnostic test.
The assay is designed for use with the company’s Sofia 2 fluorescent immunoassay analyzer for rapidly detecting the coronavirus in nasal or nasopharyngeal samples.
The immunoassay analyzer delivers automated test results in 15 minutes.
Upcoming Events
-
07May
-
14May
-
30May